| Просмотров | |
|---|---|
| Pharmacoepidemiologic and clinical rationale for the inclusion of L-arginine and dihydroquercetin in the combined pharmacotherapy of hypertensive patients with COVID-19 | 13 |
| Апрель 2025 | Май 2025 | Июнь 2025 | Июль 2025 | Август 2025 | Сентябрь 2025 | Октябрь 2025 | |
|---|---|---|---|---|---|---|---|
| Pharmacoepidemiologic and clinical rationale for the inclusion of L-arginine and dihydroquercetin in the combined pharmacotherapy of hypertensive patients with COVID-19 | 0 | 0 | 0 | 0 | 1 | 12 | 0 |
| Просмотров | |
|---|---|
| Naletova_Pharmacoepidemiologic_25.pdf | 3 |
| Просмотров | |
|---|---|
| Соединенные Штаты | 5 |
| Аргентина | 1 |
| Соединенное Королевство | 1 |
| Просмотров | |
|---|---|
| Mountain View | 3 |
| Sacramento | 2 |
| Suipacha | 1 |
| Warrington | 1 |